CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
21.85
+0.41 (1.91%)
At close: May 8, 2026, 4:00 PM EDT
21.82
-0.03 (-0.14%)
After-hours: May 8, 2026, 4:58 PM EDT
CareDx Employees
As of December 31, 2025, CareDx had 765 total employees, including 761 full-time and 4 part-time employees. The number of employees increased by 115 or 17.69% compared to the previous year.
Employees
765
Change (1Y)
115
Growth (1Y)
17.69%
Revenue / Employee
$539,634
Profits / Employee
-$10,708
Market Cap
1.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 765 | 115 | 17.69% | 761 | 4 |
| Dec 31, 2024 | 650 | 7 | 1.09% | 644 | 6 |
| Dec 31, 2023 | 643 | -95 | -12.87% | 635 | 8 |
| Dec 31, 2022 | 738 | 93 | 14.42% | 727 | 11 |
| Dec 31, 2021 | 645 | 170 | 35.79% | 633 | 12 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| GRAIL | 910 |
| Castle Biosciences | 883 |
CDNA News
- 9 days ago - CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 11 days ago - CareDx price target raised to $28 from $26 at BTIG - TheFly
- 12 days ago - CareDx files automatic mixed securities shelf - TheFly
- 12 days ago - CareDx to acquire Naveris for $160M up-front, $100M in revenue milestones - TheFly
- 12 days ago - CareDx raises FY26 revenue view to $447M-$465M from $420M-$444M - TheFly
- 12 days ago - CareDx Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - CareDx reports Q1 EPS 34c, consensus 13c - TheFly
- 12 days ago - CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing - Business Wire